Recent studies have identified a number of transcriptional regulators, including E proteins, EBF1, FOXO1, and PAX5, that act together to orchestrate the B-cell fate. However, it still remains unclear as to how they are linked at the earliest stages of B-cell development. Here, we show that lymphocyte development in HEB-ablated mice exhibits a partial developmental arrest, whereas B-cell development in E2A +/− HEB −/− mice is completely blocked at the LY6D − common lymphoid progenitor stage. We show that the transcription signatures of E2A-and HEB-ablated common lymphoid progenitors significantly overlap. Notably, we found that Foxo1 expression was substantially reduced in the LY6D
S teady state hematopoiesis relies on fine tuned transcriptional networks that are modulated by external signals from the surrounding microenvironment. Hematopoiesis is initiated in hematopoietic stem cells (HSCs). HSCs have the ability to generate the entire spectrum of hematopoietic cells as well as self-renew without losing their multilineage potential (1) . HSCs initially differentiate into multipotent progenitors (MPPs). MPPs have lost their ability to self-renew and can only transiently support hematopoiesis on transplantation (2) . The MPP compartment itself is heterogeneous and contains a subfraction of cells expressing high surface levels of fms-like tyrosine kinase 3 (FLT3), often referred to as lymphoid-primed multipotent progenitors (LMPPs) (3) . These cells have largely lost their megakarycyte/erythocyte potential (3) . Thus, LMPPs are considered to represent progenitor cells en route to a lymphoid cell fate. LMPPs are the likely precursor of the common lymphoid progenitors (CLPs), with the ability to develop into the entire spectrum of lymphoid cells (4, 5) . However, recent studies have shown that the CLP compartment is also heterogeneous, containing immature cells along with a small subset of cells committed to the B-cell lineage (6) . The CLPs can be segregated using lymphocyte antigen 6 complex, locus D (LY6D) as a marker (7, 8) . Specifically, the LY6D − CLPs represent the more immature compartment, whereas the B lineagecommitted cells can be found within the LY6D + fraction. The development of lymphoid progenitors requires the activities of an ensemble of transcriptional regulators (9) (10) (11) (12) (13) . Prominent among these regulators are the E proteins E2A, E2-2, and HeLa E-box binding protein (HEB) (14) . The E2A proteins maintain the HSC pool and promote the developmental progression of myelolymphoid and myeloerythorid progenitors during early hematopoiesis (15) (16) (17) . At the CLP cell stage, they act upstream and in concert with Early B cell factor 1 (EBF1), forkhead box O1 (FOXO1) and Paired box gene 5 (PAX5) to promote specification and commitment to the B-cell lineage (10, 13, 18, 19) . The E2A locus encodes for two isoforms, E12 and E47, that arise through differential splicing (14) . Whereas E47 plays a critical role in early B-cell development, the activity of E12 is not essential (20) . Although some T cells develop in E2A-deficient mice, the E2A proteins have also been shown to play critical roles in early thymocyte development (21) . They induce the expression of genes involved in Notch and pre-T cell receptor signaling and in turn, act in concert with Notch signaling to promote T-lineage development (21) . A unique role for the E2-2 proteins has also recently been established. Specifically, it was shown that plasmacytoid dendritic cell development is blocked in E2-2-deficient mice (22) .
HEB is expressed at high levels in developing thymocytes, where it is required to promote efficient maturation beyond the pre-TCR checkpoint (21) and induce the invariant natural killer T cell fate (23) . During fetal life, HEB is required to promote developmental progression of early thymocyte progenitors and pro-B cells (24, 25) . However, the roles of HEB in adult hematopoesis and lymphocyte development and how HEB acts in concert with E2A to promote B-cell development have not yet been carefully examined. Here, we report that HEB is broadly expressed at substantial levels within the entire spectrum of adult hematopoietic progenitors. Whereas erythroid and myeloid development seemed normal, a developmental block was observed in the CLP compartment that was similar to the block described for E2A-ablated CLPs (7, 26) . Interestingly, E2A and HEB seem to act in concert to promote B-cell development; HEB −/− and E2A +/− mice exhibit a partial block at the LY6D − CLP cell stage, whereas E2A +/− HEB −/− mice exhibit an arrest. Furthermore, HEB-and E2A-deficient LY6D − CLPs regulate an overlapping set of target genes, most notably, the transcription factor FOXO1. Finally, we identify enhancer elements, characterized by the presence of H3K4me1 islands, across the FOXO1 locus that are responsive to E2A activity. These observations directly link E2A, HEB, and FOXO1 in B-cell progenitors into a common framework that specifies the B-cell fate.
Results
Expression of E2A, HEB, Id2, and Id3 in Progenitor Cells. To characterize the patterns of E2A, HEB, Id2, and Id3 expression in bone marrow progenitor cells, mRNA was isolated from FACS-sorted progenitor populations and analyzed by real-time PCR. Both E2A and HEB were expressed in the Lineage −/low SCA1 + KIT + (LSK) compartment known to harbor the majority of the HSCs' potential (1) as well as substantial levels within the entire spectrum of hematopoietic progenitors (Fig. 1A) . Id2 was expressed at low levels in the CLP compartments, whereas Id3 expression was only detectable in the LY6D + CLP compartment (Fig. 1A) . Whereas the roles of E2A in early adult hematopoiesis have been well-docu-mented, the function of HEB in adult hematopoietic development has remained to be determined. As a first approach to this question, mice in which the HEB DNA binding regions were flanked by loxP sites (27) were bred to transgenic mice carrying a Tie2-Cre transgenic construct to generate mice where HEB is deleted from the entire hematopoietic system (Fig. S1A) . HEB f/f Tie2Cre mice were viable and fertile, and they lacked obvious developmental defects. However, on examination of bone marrow cellularity, HEB f/f Tie2Cre mice showed a small but significant reduction in the total number of nucleated cells (P = 0.025) (Fig. 1B) .
HEB Activity Is Not Essential to Promote HSCs and Myelo-Erythroid
Development. Because HEB is expressed in both the primitive LSK compartment as well as hematopoietic progenitors derived from HSCs, we analyzed the hematopoietic compartment of HEBablated mice in the adult bone marrow by flow cytometry (Fig. 1C) . The majority of the long-term HSCs can be found within a subpopulation of the LSKs expressing CD150 on the surface (28) . The CD150 + LSK and the CD150 − LSK compartments were not affected in the bone marrow of HEB f/f Tie2Cre mice (Fig. 1C) . In addition, no significant changes were found in the numbers of the Lineage low/− SCA − KIT + (LK) population known to harbor myelo-erythroid progenitors (29) (Fig. 1C) . Furthermore, because HEB has been reported to be associated with T cell acute lymphocytic leukemia 1 (TAL1), E2A, and ETO2 in erythroid cells (30) , we examined the heterogenous LK compartment (31) . No statistically significant differences were observed among these subsets, and all subpopulations were present in normal numbers in the bone marrow of HEB f/f Tie2Cre compared with WT mice (Fig.  1D ). Taken together, these observations indicate that HEB, unlike E2A, is dispensable for the steady state maintenance of HSCs and the generation of myelo-erythroid progenitors.
HEB Promotes the B-Cell Fate. An early step to the development of lymphoid-restricted cells is the development of LMPPs that are defined by the up-regulation of FLT3 in a subset of the LSK compartment. Interestingly, the LMPP compartment was significant reduced in HEB f/f Tie2Cre relative to WT mice (P = 0.0026) ( Fig. 2 A-C) . The CLP compartment was also significantly affected in HEB f/f Tie2Cre mice. Specifically, both the LY6D − CLP (P = 0.0024) and LY6D + CLP compartments (P < 0.0001) were substantially reduced ( Fig. 2 B and C) and strongly resembled the E2A +/− mice (Fig. S1B) . Cellularity of the CD19 + compartment in HEB f/f Tie2Cre bone marrow was significantly altered compared with WT bone marrow ( Fig. 2 D and E) . The total reduction in CD19 + bone marrow B-cell progenitors corresponded well to the overall reduction seen in bone marrow cellularity, suggesting that in vivo HEB f/f Tie2Cre progenitors did not adopt alternate cell fates at the expense of B-cell differentiation.
Previous studies have shown that E2A-ablated HSCs enforce a cell cycle checkpoint in HSCs (15, 16) . To explore the possibility that HEB performs a similar role in progenitor cells, the fraction of cycling progenitors was analyzed in HEB f/f Tie2Cre bone marrow. Lack of HEB in the CLP compartment did not alter the cell cycle distribution, and in contrast to E2A-deficient mice, no differences in cell cycle progression were found in the LSK and LK compartments of HEB f/f Tie2Cre mice ( Fig. 2F and Fig. S2 A and B). Furthermore, Annexin V staining revealed that HEB seemed to not be required for the viability of the cells in the CLP, LSK, and LK compartments ( Fig. 2F and Fig. S2 A and B) . These data indicate that the development of early hematopoietic progenitors in the absence of HEB resembles the development observed in E2A-deficient mice.
HEB Deficiency Interferes with the LY6D
− CLP to LY6D + CLP Transition.
B-cell development can be separated into phenotypically defined stages based on surface markers and Ig rearrangement status (Fig. 3A) . To identify the compartments where developmental progression was affected by a lack of HEB, the ratio of cell numbers of consecutive developmental steps were plotted (Fig.  3B ). This analysis indicated that a critical function of HEB is exerted during transition from the LY6D − to LY6D + cell stage. No significant changes were found in the pro-, pre-, and immature B-cell transitions, indicating that HEB is dispensable for developmental progression beyond the LY6D + stage. Rather, we suggest that the reduced numbers of CD19 + bone marrow cells present in the bone marrow of HEB f/f Tie2Cre originate from the developmental defects in the CLP compartment.
A recent study using Rag1-GFP reporter mice identified functionally distinct low and high reporter-expressing cells within the LY6D + CLP population (8) . These observations raise the question as to whether the reduced frequency of LY6D + CLPs is caused by a partial block in the LY6D − to LY6D + transition and/or a transition within the LY6D + fraction. To explore this question, single LY6D + cells were examined for the presence of Tie2Cre bone marrow. Each dot represents the number from a single mouse, and the horizontal lines are the mean in each group. Data shown are pooled from two independent experiments. MkP, megakaryocyte progenitor; GMP, granulocyte macrophage progenitor; preGM, pregranulocyte macrophage; preMegE, premegakarycocyte erythrocyte; pre-CFUE, pre-CFU erythrocyte; CFUE, CFU erythrocyte; proEry, proerythrocyte. D H J H rearrangements (Fig. 3C ). We found that the frequency of D H J H rearrangements was not altered in HEB f/f Tie2Cre mice, indicating that the distribution of subpopulations within the LY6D + CLP compartment remained unperturbed (Fig. 3C ). These data indicate that, although the lack of HEB caused a partial block in the transition from LY6D
− to LY6D + CLPs, development within the LY6D + compartment was not significantly altered in the absence of HEB.
The data described above indicate that HEB acts to promote specification to the B-cell fate. To directly evaluate how HEB acts in progenitors, we evaluated the in vitro B-cell developmental potential of HEB f/f Tie2Cre LY6D
− progenitors using a limiting dilution assay approach; 1, 3, 5, or 10 uncommitted LY6D − CLPs were plated on OP9 stroma cells in the presence of the cytokines FLT3-Ligand, IL-7, and stem cell factor. On culturing the cells for 14 d, the number of cells plated per well was plotted against the percentages of wells negative for B-cell growth, which were measured by CD19 expression. The frequency of LY6D − CLPs containing in vitro B-cell potential was determined as the concentration of cells in which 37% of the wells lacked B cells (32) . One of five WT cells developed into B cells (Fig. 3D ). In contrast, only one of nine cells of the HEB-deficient cells progressed to the committed B-cell stage (Fig. 3D) . These data indicate a 50% reduction in the ability of HEB-ablated progenitors to differentiate into committed B cells. These data correspond well with the decrease observed in the HEB-deficient bone marrow. In contrast, HEB Each dot represents the number from a single mouse, and the horizontal lines are the mean in each group. Data shown are pooled from two independent experiments. *P < 0.05; ***P < 0.001. F Left displays the cell cycle distribution (quantified by Ki67 and 7AAD FACS staining) of WT and HEB-deficient CLPs (n = 3 in each group). F Right shows a representative plot of Annexin V staining comparing WT and HEB-deficient CLPs (total n = 3 in each group). For F Left and F Right, CLPs are defined as depicted in B. S3). Collectively, these data indicate that HEB acts in the CLP compartment to specify the B-cell fate.
HEB and E2A Act in Concert to Specify the B-Cell Fate. The data described above indicate a critical role for HEB in promoting Blineage specification in a manner similar to the role described for E2A. To determine whether E2A and HEB act together to specify the B-cell fate, E2A and HEB compound mice were generated and analyzed by flow cytometry for abnormalities in early hematopoiesis. Because Tie2Cre expression did not efficiently excise E2A alleles in E2A f/f mice (27), we used Vav-iCre transgenic mice to achieve a higher degree of excision. E2A f/f VaviCre and HEB f/f Vav-iCre displayed the same hematopoietic phenotype as the E2A −/− and HEB f/f Tie2Cre mice ( Fig. 4A and Fig. S4 ). Next, we compared HEB f/f Vav-iCre, E2A f/+ Vav-iCre, and E2A f/+ HEB f/f Vav-iCre mice for abnormalities in CLP development (Fig. 4A) . As expected, E2A
f/+ Vav-iCre and HEB f/f Vav-iCre mice exhibited a partial block at the CLP cell stage (Fig. 4A) . However, the LY6D + compartment was close to absent in E2A f/+ HEB f/f VaviCre mice (Fig. 4A) . These data indicate that E2A and HEB act in concert to initiate B-cell development.
To determine how E2A and HEB act in the CLP compartment to prime the B-cell fate, we performed microarray analysis using mRNA from sorted LY6D − CLPs derived from HEB f/f Tie2Cre mice. Notably, only 18 genes were altered by a factor of more than twofold in HEB f/f Tie2Cre vs. WT LY6D − CLPs (Fig. 4B ). To verify that chemokine (C-C motif) receptor 9 (CCR9), a previously identified E2A target, is also regulated by HEB, HEB-ablated CLPs were analyzed for the expression of Ccr9 by flow cytometry (17) . As predicted, Ccr9 expression was substantially reduced in HEB f/f Tie2Cre LY6D − CLPs (Fig. 4C ). To directly evaluate the extent to which E2A and HEB share a common set of target genes, mRNA from E2A −/− LY6D − CLPs was next examined by microarray analysis. The majority of the genes altered in the absence of HEB exhibited a similar change as depletion of E2A activity (Fig. 4B) .
To further explore the possibility that HEB and E2A share a common set of target genes in the LY6D
− compartment, we examined the entire spectrum of genes changed in the absence of E2A; 197 transcripts were up-or down-regulated more than twofold in E2A-deficient LY6D
− CLPS compared with the corresponding WT cells (Fig. 4D Left and Table S1 ). We next examined how these genes were changed in the absence of HEB. This analysis revealed a striking pattern of E-protein dose dependency (Fig. 4D  Right) . Genes up-or down-regulated by E2A were, in general, also affected by the absence of HEB, albeit to a lower degree. Among the changed transcripts were Ccr9, Id2, Blnk, Dntt, Notch1, IL-7ra, and most notably, Foxo1. These data indicate that E2A and HEB CLPs. ***P < 0.001. Displayed data are the means derived from two or more microarray replicas using material from independent sorts.
share a large set of common target genes and that it is the dosage of E proteins that promotes the development of LY6D + CLPs.
Regulation of Foxo1 Expression by the E Proteins. The microarray data described above indicate that both E2A and HEB are required to activate normal FOXO1 expression in the CLP compartment. To quantitatively compare FOXO1 transcript levels in WT and HEB-and E2A-deficient CLPs, mRNA derived from each of the populations was examined by real-time PCR. Consistent with the microarray data, FOXO1 transcript levels were reduced in both HEB f/f Tie2Cre and E2A −/− CLPs (Fig. 5A) .
−/− hematopoietic progenitors (10). On inspection of epigenetic marks across the FOXO1 locus, we identified high-affinity E2A binding sites in putative enhancers as well in the promoter region (Fig. 5B) (10) . Subsequently, the putative enhancer and promoter regions, containing the identified WT as well as mutated E-box sites, were inserted into an enhancer luciferase reporter construct, transfected into pro-B cells, and assayed for transcriptional activity. Notably, deletion of the E-box sites substantially interfered with reporter activity (Fig. 5C ) (P peak1 = 0.0178, P peak2 = 0.047). Thus, these data indicate that E-protein activity directly regulates Foxo1 expression (Fig. 5D ).
Discussion
Previous observations have indicated that the E2A proteins play critical roles throughout hematopoiesis. In the HSC compartment, the E2A proteins maintain the hematopoietic stem cell pool (15, 16) , and in developing progenitors, the E2A proteins promote the developmental progression of erythroid/megakaryocytic and myeloid progenitors (15) . However, perhaps most prominent is the block observed in the CLP compartment in E2A-deficient mice at a stage in which B-cell development is initiated (7, 26) . Specifically, although the LY6D − CLP compartment in E2A-deficient mice is present, albeit in reduced numbers, the LY6D + compartment is complete absent (7) . Here, we show that E2A and HEB mechanistically act together to specify the B-cell fate.
Whereas HSCs were not significantly perturbed in HEB-deficient mice, we observed a clear reduction in B-cell progenitors in the adult bone marrow. The defect in B-lymphoid differentiation was initiated in the LMPP compartment but manifested predominantly during the LY6D − to LYD6 + CLP transition. However, committed B-lineage cells derived from the LY6D + CLP compartment developed in expected ratios. Thus, these data indicate that the partial block in the LY6D − to LY6D + CLP transition is the major cause for the observed reduction in B-cell progenitor numbers in HEB-deficient bone marrow. Furthermore, HEB f/f VaviCre and E2A f/+ VaviCre mice show a partial block at the CLP cell stage, whereas HEB f/f E2A f/+ VaviCre mice display a more complete arrested block in the LY6D − compartment. Consistent with these observations, using microarray analysis, we show that the transcription signatures of E2A-and HEB-deficient CLPs substantially overlap.
We are now faced with the question as to how HEB and E2A act at the LY6D − CLP cell stage to initiate a B lineage-specific program of gene expression. Here, we show that Foxo1 expression is reduced in the absence of E proteins. A genome-wide screen for E2A binding sites revealed that the E2A proteins bind to regulatory elements present in the FOXO1 locus (10), and we show that these E2A binding sites indeed play a role in modulating FOXO1 expression. In addition to the E proteins, an ensemble of transcriptional regulators has been shown to play critical roles in early B-cell development. Among these regulators are EBF1, PU.1, FOXO1, and PAX5 (13, 33) . Furthermore, IL-7R-mediated signaling also has been proposed to modulate EBF1 expression (34) (35) (36) . How is this spectrum of transcriptional regulators connected to orchestrate the B-cell fate? Based on previous data as well as the observations described here, we would like to propose that, in LY6D − CLPs, E2A and HEB act in concert to induce the expression of FOXO1. FOXO1, in turn, together with E2A, HEB, and PU.1 as well as IL-7R-mediated signaling, then activates the expression of EBF1 in LY6D + CLPs. E2A, FOXO1, EBF1, and IRF4 as well as IRF8 subsequently induce the expression of PAX5 (10, 13, 37, 38) . These data bring into question how the E proteins are activated in the CLP LY6D − compartment. E2A protein levels do not change significantly during the developmental progression from the HSC to the CLP cell stage (15) . In addition, we show here that Id2 and Id3 mRNA levels do not change substantially during the developmental progression from the LSK to the CLP cell stage. The question then arises as to why a B lineage-specific program gene expression is not induced at the HSC or LMPP cell stage. We would like to suggest that transcriptional repression rather than activation regulates the expression of FOXO1 during early hematopoiesis, because the low levels of FOXO1 expression are not affected in E2A-ablated LMPPs (17) . Thus, before reaching the CLP compartment, FOXO1 levels are kept low by active repression. On reaching the CLP compartment, the activities of transcriptional repressors are blocked, permitting E2A and HEB to induce FOXO1 transcription and specify the B-cell fate. The critical problem now will be to determine how the activation of a B lineage-specific program of gene expression by the E proteins is suppressed during the earlier stages of hematopoiesis. 
Materials and Methods
Mice. HEBf/f and E2Af/f mice were a gift from Yuan Zhuang (Duke University, Durham, NC). Tie2Cre and VaviCre mice were purchased from The Jackson Laboratory. E2A-deficient mice have been previously described (9 RNA Analysis. Quantitative RT-PCR analysis of sorted cells was performed as previously described (6) . Assays on Demand (Applied Biosystems) probes used were Hprt (Mm00446968_m1), E2A (Mm01175598_m1), HEB (Mm00441699_m1), Id2 (Mm00711781_m1), and Id3 (Mm00492575_m1). All experiments were performed in duplicate at least two times using cells from independent sorts.
IgH D-J Rearrangements in Single Cells. Nested single-cell PCR has been previously described (26) and was performed with slight modifications. Briefly, single-cell LY6D + CLPs were sorted directly into 96-well plates containing PCR buffer containing 20 mM Tris·HCl 50 mM KCl (pH 8.4), snap-frozen, and stored in −80°C. In the first round, PCR amplification was performed with,
second round of PCRs. Second-round primers were used at 2 μM concentrations. Only samples producing either a germline product and/or a specific rearrangement product are included in the analysis.
Annexin V Staining. After staining with appropriate surface markers, cells were stained using Annexin V Apoptosis detection kit (eBioscience) according to manufacturer's instructions.
Cell Cycle Analysis. Cells were fixed with the BD Cytofix/Cytoperm solution kit (BD Bioscience) followed by incubation with anti-human Ki67 (BD Bioscience) and 7AAD according to manufacturer's instructions.
In Vitro Evaluation of B-and T-Cell Potential by OP9 Coculture. For evaluation of in vitro B-cell potential, 1, 3, 5, or 10 cells/well were deposited (using a FACSAria) directly into 96-well plates containing preplated OP9 cells. In each experiment, 10 or more wells were analyzed per cell concentration. For evaluation of in vitro T-cell potential, single cells were deposited on preplated OP9DL1 cells in similar conditions as the B-cell cultures. Culture conditions and FACS evaluations have been previously described (6) . Frequencies from limiting dilution assays were calculated as previously described (32) .
Affymetrix Gene Expression and Data Analysis. Gene expression assays have been previously described (8) .
Luciferase Assays. Luciferase assays were performed as previously described (10). The table contains genes displaying a greater than or equal to twofold difference in expression between WT and E2A-deficient LY6D − CLPs. Data displayed are the means from more than or equal to two microarray replicas using material from independent sorts.
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